TrialNature cancer2025

Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer.

Justin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.